Nanotechnology : Research Triangle Park

North Carolina Biotechnology Center

Benj — Mon, 27 Aug 2007 10:25:54 +0000

Ticker Id

Web url

http://www.ncbiotech.org/

Contact Email

info@ncbiotech.org

Short description

Street address

15 T.W. Alexander Drive, Post Office Box 13547

Zip or postal code

27709-3547

Telephone

919.541.9366

Fax

919.990.9544

Foundation date

Ceo, president

Number of employees

Long description

In the early 1980s, the state’s General Assembly appointed a legislative study commission to determine how North Carolina could ensure long-term economic benefits from biotechnology.

A yearlong study by the commission concluded that North Carolina needed a private, non-profit organization dedicated exclusively to biotechnology development.

The state legislatures then established the North Carolina Biotechnology Center, headquartered in Research Triangle Park, as the world’s first government-sponsored organization dedicated to developing the biotechnology industry.
Mission

The 66-member staff seeks to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide.

The Biotechnology Center is not a site for laboratory research or company incubation. Instead, it works to strengthen the research capabilities of North Carolina’s companies and universities.

This strategy avoids duplication of effort and uses limited resources more efficiently.
Funding

The Biotechnology Center receives nearly all of its funding from the General Assembly. Our state appropriation for FY 06-07 is $13.1 million, and our budget for the year is $17.6 million.

Since 1984 the Biotechnology Center has invested more than $187 million in state monies to develop biotechnology statewide.

Additional Commentaries and remarks

Patents

Xintek, Inc.

Benj — Fri, 18 Aug 2006 15:41:37 +0000

Ticker Id

Web url

http://www.xintek.com/

Contact Email

info@xintek.com

Short description

Street address

7020 Kit Creek Road Suite 280, Research Triangle Park

Zip or postal code

27709

Telephone

919-313-9638

Fax

919-313-9639

Foundation date

Ceo, president

Number of employees

Long description

Applied Nanotechnologies, Inc. has changed its name to Xintek, Inc. as of March 1 of 2004.

The company was initially established in October 2000 to develop and commercialize applications of carbon nanotubes in various industries such as telecommunications, electronics and medical imaging systems. The Company also fabricates carbon nanotubes for use in the above-mentioned industries and the research community.

The Company obtained the exclusive license of proprietary technologies developed by the Companys co-founder Dr. Otto Zhou and his collaborators from the University of North Carolina at Chapel Hill (UNC-CH). Dr. ZhouТ’s research at UNC-CH has been supported by the federal agencies including the Department of Defense, NASA and the National Science Foundation. Dr. Zhou is the director of the North Carolina Center for Nanoscale Materials with participants from UNC, Duke and NCSU.

Additional Commentaries and remarks

Patents

Liquidia Technologies

Benj — Wed, 16 Aug 2006 19:29:47 +0000

Ticker Id

Web url

http://www.liquidia.com/

Contact Email

info@liquidia.com

Short description

Street address

P.O. Box 110085

Zip or postal code

27709

Telephone

(919) 991-0835

Fax

(919) 991-0827

Foundation date

Ceo, president

Number of employees

Long description

Founded in Chapel Hill, North Carolina, Liquidia Technologies develops and markets innovative fluoropolymer materials for high-value industrial applications in a broad range of industries including chemical, life science, electronic, and consumer goods companies. Liquidia Technologies arose from an innovative fluoropolymer materials discovery by Prof. DeSimone and his team at The University of North Carolina at Chapel Hill & North Carolina State University. Liquidia pursues strategic partnerships that enable selective access to our intellectual property through patent licensing, product sales tied to label licensing, and co-development agreements, including access to our broad methodology patents.